nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—CYP2D6—Alzheimer's disease	0.196	1	CbGaD
Gefitinib—CYP2D6—Rivastigmine—Alzheimer's disease	0.0632	0.179	CbGbCtD
Gefitinib—CYP2C19—Memantine—Alzheimer's disease	0.0576	0.164	CbGbCtD
Gefitinib—CYP2C9—Donepezil—Alzheimer's disease	0.0552	0.157	CbGbCtD
Gefitinib—CYP2D6—Donepezil—Alzheimer's disease	0.0505	0.143	CbGbCtD
Gefitinib—CYP3A4—Rivastigmine—Alzheimer's disease	0.0402	0.114	CbGbCtD
Gefitinib—CYP2D6—Galantamine—Alzheimer's disease	0.0326	0.0924	CbGbCtD
Gefitinib—CYP3A4—Donepezil—Alzheimer's disease	0.0321	0.0912	CbGbCtD
Gefitinib—CYP3A4—Galantamine—Alzheimer's disease	0.0207	0.0588	CbGbCtD
Gefitinib—ERBB3—embryo—Alzheimer's disease	0.00218	0.0319	CbGeAlD
Gefitinib—CSNK1E—forebrain—Alzheimer's disease	0.002	0.0292	CbGeAlD
Gefitinib—ERBB3—forebrain—Alzheimer's disease	0.00193	0.0282	CbGeAlD
Gefitinib—EGFR—telencephalon—Alzheimer's disease	0.00191	0.028	CbGeAlD
Gefitinib—SBK1—cerebellum—Alzheimer's disease	0.00185	0.0271	CbGeAlD
Gefitinib—CSNK1E—telencephalon—Alzheimer's disease	0.00184	0.0269	CbGeAlD
Gefitinib—Blepharitis—Memantine—Alzheimer's disease	0.00183	0.00953	CcSEcCtD
Gefitinib—Blepharitis—Rivastigmine—Alzheimer's disease	0.00179	0.00932	CcSEcCtD
Gefitinib—ERBB3—telencephalon—Alzheimer's disease	0.00177	0.0259	CbGeAlD
Gefitinib—Electrocardiogram QT prolonged—Memantine—Alzheimer's disease	0.00175	0.00913	CcSEcCtD
Gefitinib—Electrocardiogram QT prolonged—Rivastigmine—Alzheimer's disease	0.00171	0.00893	CcSEcCtD
Gefitinib—Nail disorder—Rivastigmine—Alzheimer's disease	0.00169	0.00884	CcSEcCtD
Gefitinib—MKNK2—telencephalon—Alzheimer's disease	0.00168	0.0247	CbGeAlD
Gefitinib—IRAK1—telencephalon—Alzheimer's disease	0.00168	0.0247	CbGeAlD
Gefitinib—MKNK1—telencephalon—Alzheimer's disease	0.00166	0.0244	CbGeAlD
Gefitinib—Seborrhoeic dermatitis—Rivastigmine—Alzheimer's disease	0.00161	0.00841	CcSEcCtD
Gefitinib—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00156	0.00814	CcSEcCtD
Gefitinib—Melaena—Galantamine—Alzheimer's disease	0.00156	0.00814	CcSEcCtD
Gefitinib—Rash pustular—Donepezil—Alzheimer's disease	0.00155	0.00809	CcSEcCtD
Gefitinib—Cystitis—Galantamine—Alzheimer's disease	0.00154	0.00804	CcSEcCtD
Gefitinib—EPHA6—nervous system—Alzheimer's disease	0.00153	0.0225	CbGeAlD
Gefitinib—Haemoptysis—Memantine—Alzheimer's disease	0.00152	0.00792	CcSEcCtD
Gefitinib—SBK1—brain—Alzheimer's disease	0.0015	0.022	CbGeAlD
Gefitinib—HIPK4—brain—Alzheimer's disease	0.00148	0.0217	CbGeAlD
Gefitinib—EPHA6—central nervous system—Alzheimer's disease	0.00148	0.0216	CbGeAlD
Gefitinib—Bladder pain—Galantamine—Alzheimer's disease	0.00144	0.00753	CcSEcCtD
Gefitinib—Pleural effusion—Rivastigmine—Alzheimer's disease	0.00143	0.00749	CcSEcCtD
Gefitinib—MAP3K19—nervous system—Alzheimer's disease	0.00139	0.0204	CbGeAlD
Gefitinib—MAP3K19—central nervous system—Alzheimer's disease	0.00134	0.0197	CbGeAlD
Gefitinib—CHEK2—brain—Alzheimer's disease	0.00131	0.0191	CbGeAlD
Gefitinib—MAP2K5—telencephalon—Alzheimer's disease	0.00122	0.0179	CbGeAlD
Gefitinib—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00122	0.00638	CcSEcCtD
Gefitinib—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00121	0.00631	CcSEcCtD
Gefitinib—Melaena—Donepezil—Alzheimer's disease	0.00121	0.00631	CcSEcCtD
Gefitinib—Cystitis—Donepezil—Alzheimer's disease	0.00119	0.00623	CcSEcCtD
Gefitinib—Bosutinib—PTK2B—Alzheimer's disease	0.00118	0.169	CrCbGaD
Gefitinib—Bosutinib—LRRK2—Alzheimer's disease	0.00118	0.169	CrCbGaD
Gefitinib—EPHA6—brain—Alzheimer's disease	0.00117	0.0172	CbGeAlD
Gefitinib—Respiratory failure—Memantine—Alzheimer's disease	0.00114	0.00597	CcSEcCtD
Gefitinib—Dry eye—Donepezil—Alzheimer's disease	0.00114	0.00596	CcSEcCtD
Gefitinib—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00112	0.00584	CcSEcCtD
Gefitinib—Bladder pain—Donepezil—Alzheimer's disease	0.00112	0.00584	CcSEcCtD
Gefitinib—Melaena—Memantine—Alzheimer's disease	0.0011	0.00573	CcSEcCtD
Gefitinib—Cystitis noninfective—Memantine—Alzheimer's disease	0.0011	0.00573	CcSEcCtD
Gefitinib—Cystitis—Memantine—Alzheimer's disease	0.00108	0.00566	CcSEcCtD
Gefitinib—CSNK1E—nervous system—Alzheimer's disease	0.00108	0.0159	CbGeAlD
Gefitinib—Dehydration—Galantamine—Alzheimer's disease	0.00108	0.00562	CcSEcCtD
Gefitinib—Melaena—Rivastigmine—Alzheimer's disease	0.00107	0.0056	CcSEcCtD
Gefitinib—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.00107	0.0056	CcSEcCtD
Gefitinib—IRAK4—nervous system—Alzheimer's disease	0.00107	0.0156	CbGeAlD
Gefitinib—MAP3K19—brain—Alzheimer's disease	0.00107	0.0156	CbGeAlD
Gefitinib—EGFR—cerebellum—Alzheimer's disease	0.00106	0.0155	CbGeAlD
Gefitinib—Cystitis—Rivastigmine—Alzheimer's disease	0.00106	0.00554	CcSEcCtD
Gefitinib—Hypokalaemia—Galantamine—Alzheimer's disease	0.00105	0.0055	CcSEcCtD
Gefitinib—ERBB3—nervous system—Alzheimer's disease	0.00105	0.0153	CbGeAlD
Gefitinib—CSNK1E—central nervous system—Alzheimer's disease	0.00104	0.0153	CbGeAlD
Gefitinib—IRAK4—central nervous system—Alzheimer's disease	0.00103	0.015	CbGeAlD
Gefitinib—CSNK1E—cerebellum—Alzheimer's disease	0.00102	0.0149	CbGeAlD
Gefitinib—Mouth ulceration—Memantine—Alzheimer's disease	0.00102	0.0053	CcSEcCtD
Gefitinib—Bladder pain—Memantine—Alzheimer's disease	0.00102	0.0053	CcSEcCtD
Gefitinib—ERBB3—central nervous system—Alzheimer's disease	0.00101	0.0147	CbGeAlD
Gefitinib—IRAK4—cerebellum—Alzheimer's disease	0.001	0.0147	CbGeAlD
Gefitinib—MKNK2—nervous system—Alzheimer's disease	0.000995	0.0146	CbGeAlD
Gefitinib—Mouth ulceration—Rivastigmine—Alzheimer's disease	0.000993	0.00518	CcSEcCtD
Gefitinib—Bladder pain—Rivastigmine—Alzheimer's disease	0.000993	0.00518	CcSEcCtD
Gefitinib—ERBB3—cerebellum—Alzheimer's disease	0.000984	0.0144	CbGeAlD
Gefitinib—MKNK1—nervous system—Alzheimer's disease	0.000982	0.0144	CbGeAlD
Gefitinib—Minaprine—ACHE—Alzheimer's disease	0.000964	0.138	CrCbGaD
Gefitinib—MKNK2—central nervous system—Alzheimer's disease	0.000958	0.014	CbGeAlD
Gefitinib—Atrial fibrillation—Donepezil—Alzheimer's disease	0.000947	0.00494	CcSEcCtD
Gefitinib—MKNK1—central nervous system—Alzheimer's disease	0.000946	0.0138	CbGeAlD
Gefitinib—Thrombophlebitis—Memantine—Alzheimer's disease	0.000942	0.00492	CcSEcCtD
Gefitinib—Dermatitis bullous—Donepezil—Alzheimer's disease	0.000939	0.0049	CcSEcCtD
Gefitinib—MKNK2—cerebellum—Alzheimer's disease	0.000936	0.0137	CbGeAlD
Gefitinib—IRAK1—cerebellum—Alzheimer's disease	0.000936	0.0137	CbGeAlD
Gefitinib—MKNK1—cerebellum—Alzheimer's disease	0.000924	0.0135	CbGeAlD
Gefitinib—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.000921	0.00481	CcSEcCtD
Gefitinib—Hepatic failure—Memantine—Alzheimer's disease	0.000907	0.00473	CcSEcCtD
Gefitinib—Weight decreased—Galantamine—Alzheimer's disease	0.000906	0.00473	CcSEcCtD
Gefitinib—Eye pain—Memantine—Alzheimer's disease	0.000903	0.00471	CcSEcCtD
Gefitinib—Pneumonia—Galantamine—Alzheimer's disease	0.000898	0.00469	CcSEcCtD
Gefitinib—Eye pain—Rivastigmine—Alzheimer's disease	0.000883	0.00461	CcSEcCtD
Gefitinib—EGFR—brain—Alzheimer's disease	0.000862	0.0126	CbGeAlD
Gefitinib—Atrial fibrillation—Memantine—Alzheimer's disease	0.00086	0.00449	CcSEcCtD
Gefitinib—Dermatitis bullous—Memantine—Alzheimer's disease	0.000853	0.00445	CcSEcCtD
Gefitinib—Haematuria—Galantamine—Alzheimer's disease	0.000851	0.00444	CcSEcCtD
Gefitinib—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000844	0.00441	CcSEcCtD
Gefitinib—Iloperidone—HTR6—Alzheimer's disease	0.000844	0.121	CrCbGaD
Gefitinib—Epistaxis—Galantamine—Alzheimer's disease	0.000842	0.0044	CcSEcCtD
Gefitinib—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000842	0.00439	CcSEcCtD
Gefitinib—Dehydration—Donepezil—Alzheimer's disease	0.000835	0.00436	CcSEcCtD
Gefitinib—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000834	0.00436	CcSEcCtD
Gefitinib—CSNK1E—brain—Alzheimer's disease	0.000829	0.0121	CbGeAlD
Gefitinib—Dry skin—Donepezil—Alzheimer's disease	0.000823	0.0043	CcSEcCtD
Gefitinib—Hypokalaemia—Donepezil—Alzheimer's disease	0.000817	0.00426	CcSEcCtD
Gefitinib—IRAK4—brain—Alzheimer's disease	0.000816	0.0119	CbGeAlD
Gefitinib—STK10—nervous system—Alzheimer's disease	0.000809	0.0118	CbGeAlD
Gefitinib—Aspartate aminotransferase increased—Donepezil—Alzheimer's disease	0.000809	0.00422	CcSEcCtD
Gefitinib—Haemoglobin—Galantamine—Alzheimer's disease	0.000806	0.0042	CcSEcCtD
Gefitinib—Hepatitis—Galantamine—Alzheimer's disease	0.000801	0.00418	CcSEcCtD
Gefitinib—Haemorrhage—Galantamine—Alzheimer's disease	0.000801	0.00418	CcSEcCtD
Gefitinib—ERBB3—brain—Alzheimer's disease	0.0008	0.0117	CbGeAlD
Gefitinib—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000792	0.00413	CcSEcCtD
Gefitinib—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000792	0.00413	CcSEcCtD
Gefitinib—Oedema peripheral—Galantamine—Alzheimer's disease	0.00079	0.00412	CcSEcCtD
Gefitinib—Urethral disorder—Galantamine—Alzheimer's disease	0.000786	0.0041	CcSEcCtD
Gefitinib—STK10—central nervous system—Alzheimer's disease	0.000779	0.0114	CbGeAlD
Gefitinib—STK10—cerebellum—Alzheimer's disease	0.000761	0.0111	CbGeAlD
Gefitinib—Pancreatitis—Donepezil—Alzheimer's disease	0.000761	0.00397	CcSEcCtD
Gefitinib—MKNK2—brain—Alzheimer's disease	0.00076	0.0111	CbGeAlD
Gefitinib—IRAK1—brain—Alzheimer's disease	0.00076	0.0111	CbGeAlD
Gefitinib—Dehydration—Memantine—Alzheimer's disease	0.000758	0.00396	CcSEcCtD
Gefitinib—MKNK1—brain—Alzheimer's disease	0.000751	0.011	CbGeAlD
Gefitinib—Eye disorder—Galantamine—Alzheimer's disease	0.000749	0.00391	CcSEcCtD
Gefitinib—Dry skin—Memantine—Alzheimer's disease	0.000747	0.0039	CcSEcCtD
Gefitinib—Cardiac disorder—Galantamine—Alzheimer's disease	0.000744	0.00388	CcSEcCtD
Gefitinib—Hypokalaemia—Memantine—Alzheimer's disease	0.000742	0.00387	CcSEcCtD
Gefitinib—Dehydration—Rivastigmine—Alzheimer's disease	0.000742	0.00387	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.000734	0.00383	CcSEcCtD
Gefitinib—Dry skin—Rivastigmine—Alzheimer's disease	0.000731	0.00382	CcSEcCtD
Gefitinib—Angiopathy—Galantamine—Alzheimer's disease	0.000727	0.0038	CcSEcCtD
Gefitinib—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000726	0.00379	CcSEcCtD
Gefitinib—MAP2K5—nervous system—Alzheimer's disease	0.000722	0.0106	CbGeAlD
Gefitinib—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000719	0.00375	CcSEcCtD
Gefitinib—Arrhythmia—Galantamine—Alzheimer's disease	0.000716	0.00374	CcSEcCtD
Gefitinib—Weight decreased—Donepezil—Alzheimer's disease	0.000702	0.00366	CcSEcCtD
Gefitinib—Malnutrition—Galantamine—Alzheimer's disease	0.000698	0.00364	CcSEcCtD
Gefitinib—Pneumonia—Donepezil—Alzheimer's disease	0.000696	0.00363	CcSEcCtD
Gefitinib—MAP2K5—central nervous system—Alzheimer's disease	0.000695	0.0102	CbGeAlD
Gefitinib—Infestation—Donepezil—Alzheimer's disease	0.000692	0.00361	CcSEcCtD
Gefitinib—Infestation NOS—Donepezil—Alzheimer's disease	0.000692	0.00361	CcSEcCtD
Gefitinib—Pancreatitis—Memantine—Alzheimer's disease	0.000691	0.00361	CcSEcCtD
Gefitinib—MAP2K5—cerebellum—Alzheimer's disease	0.00068	0.00995	CbGeAlD
Gefitinib—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000676	0.00353	CcSEcCtD
Gefitinib—Conjunctivitis—Donepezil—Alzheimer's disease	0.000673	0.00351	CcSEcCtD
Gefitinib—Haematuria—Donepezil—Alzheimer's disease	0.00066	0.00344	CcSEcCtD
Gefitinib—Epistaxis—Donepezil—Alzheimer's disease	0.000653	0.00341	CcSEcCtD
Gefitinib—Anaemia—Galantamine—Alzheimer's disease	0.000645	0.00337	CcSEcCtD
Gefitinib—Weight decreased—Memantine—Alzheimer's disease	0.000637	0.00333	CcSEcCtD
Gefitinib—Pneumonia—Memantine—Alzheimer's disease	0.000632	0.0033	CcSEcCtD
Gefitinib—Malaise—Galantamine—Alzheimer's disease	0.000629	0.00328	CcSEcCtD
Gefitinib—Infestation—Memantine—Alzheimer's disease	0.000628	0.00328	CcSEcCtD
Gefitinib—Infestation NOS—Memantine—Alzheimer's disease	0.000628	0.00328	CcSEcCtD
Gefitinib—Haemoglobin—Donepezil—Alzheimer's disease	0.000624	0.00326	CcSEcCtD
Gefitinib—Weight decreased—Rivastigmine—Alzheimer's disease	0.000624	0.00325	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000623	0.00325	CcSEcCtD
Gefitinib—Hepatitis—Donepezil—Alzheimer's disease	0.000621	0.00324	CcSEcCtD
Gefitinib—Haemorrhage—Donepezil—Alzheimer's disease	0.000621	0.00324	CcSEcCtD
Gefitinib—STK10—brain—Alzheimer's disease	0.000618	0.00905	CbGeAlD
Gefitinib—Pneumonia—Rivastigmine—Alzheimer's disease	0.000618	0.00323	CcSEcCtD
Gefitinib—Infestation—Rivastigmine—Alzheimer's disease	0.000615	0.00321	CcSEcCtD
Gefitinib—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000615	0.00321	CcSEcCtD
Gefitinib—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000613	0.0032	CcSEcCtD
Gefitinib—Oedema peripheral—Donepezil—Alzheimer's disease	0.000612	0.00319	CcSEcCtD
Gefitinib—Conjunctivitis—Memantine—Alzheimer's disease	0.000611	0.00319	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000609	0.00318	CcSEcCtD
Gefitinib—Urethral disorder—Donepezil—Alzheimer's disease	0.000609	0.00318	CcSEcCtD
Gefitinib—Cough—Galantamine—Alzheimer's disease	0.000609	0.00318	CcSEcCtD
Gefitinib—ABCB1—blood vessel—Alzheimer's disease	0.000605	0.00886	CbGeAlD
Gefitinib—Haematuria—Memantine—Alzheimer's disease	0.000599	0.00313	CcSEcCtD
Gefitinib—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000597	0.00312	CcSEcCtD
Gefitinib—ABCG2—telencephalon—Alzheimer's disease	0.000595	0.00872	CbGeAlD
Gefitinib—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000594	0.0031	CcSEcCtD
Gefitinib—Epistaxis—Memantine—Alzheimer's disease	0.000593	0.00309	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00059	0.00308	CcSEcCtD
Gefitinib—ORM1—nervous system—Alzheimer's disease	0.000586	0.00859	CbGeAlD
Gefitinib—Haematuria—Rivastigmine—Alzheimer's disease	0.000586	0.00306	CcSEcCtD
Gefitinib—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000581	0.00303	CcSEcCtD
Gefitinib—Dry mouth—Galantamine—Alzheimer's disease	0.000581	0.00303	CcSEcCtD
Gefitinib—Epistaxis—Rivastigmine—Alzheimer's disease	0.00058	0.00303	CcSEcCtD
Gefitinib—Haemoglobin—Memantine—Alzheimer's disease	0.000567	0.00296	CcSEcCtD
Gefitinib—ORM1—central nervous system—Alzheimer's disease	0.000565	0.00827	CbGeAlD
Gefitinib—Haemorrhage—Memantine—Alzheimer's disease	0.000564	0.00294	CcSEcCtD
Gefitinib—Hepatitis—Memantine—Alzheimer's disease	0.000564	0.00294	CcSEcCtD
Gefitinib—Shock—Galantamine—Alzheimer's disease	0.00056	0.00292	CcSEcCtD
Gefitinib—Nervous system disorder—Galantamine—Alzheimer's disease	0.000558	0.00291	CcSEcCtD
Gefitinib—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000558	0.00291	CcSEcCtD
Gefitinib—Urinary tract disorder—Memantine—Alzheimer's disease	0.000557	0.00291	CcSEcCtD
Gefitinib—Oedema peripheral—Memantine—Alzheimer's disease	0.000556	0.0029	CcSEcCtD
Gefitinib—Arrhythmia—Donepezil—Alzheimer's disease	0.000555	0.0029	CcSEcCtD
Gefitinib—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000555	0.00289	CcSEcCtD
Gefitinib—Skin disorder—Galantamine—Alzheimer's disease	0.000553	0.00289	CcSEcCtD
Gefitinib—Urethral disorder—Memantine—Alzheimer's disease	0.000553	0.00289	CcSEcCtD
Gefitinib—MAP2K5—brain—Alzheimer's disease	0.000552	0.00808	CbGeAlD
Gefitinib—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000552	0.00288	CcSEcCtD
Gefitinib—Hepatitis—Rivastigmine—Alzheimer's disease	0.000552	0.00288	CcSEcCtD
Gefitinib—Alopecia—Donepezil—Alzheimer's disease	0.000549	0.00286	CcSEcCtD
Gefitinib—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000545	0.00284	CcSEcCtD
Gefitinib—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000544	0.00284	CcSEcCtD
Gefitinib—Anorexia—Galantamine—Alzheimer's disease	0.000543	0.00283	CcSEcCtD
Gefitinib—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000541	0.00282	CcSEcCtD
Gefitinib—Malnutrition—Donepezil—Alzheimer's disease	0.000541	0.00282	CcSEcCtD
Gefitinib—Erythema multiforme—Memantine—Alzheimer's disease	0.000533	0.00278	CcSEcCtD
Gefitinib—Hypotension—Galantamine—Alzheimer's disease	0.000532	0.00278	CcSEcCtD
Gefitinib—Eye disorder—Memantine—Alzheimer's disease	0.000527	0.00275	CcSEcCtD
Gefitinib—Cardiac disorder—Memantine—Alzheimer's disease	0.000523	0.00273	CcSEcCtD
Gefitinib—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000522	0.00272	CcSEcCtD
Gefitinib—Eye disorder—Rivastigmine—Alzheimer's disease	0.000516	0.00269	CcSEcCtD
Gefitinib—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000512	0.00267	CcSEcCtD
Gefitinib—Angiopathy—Memantine—Alzheimer's disease	0.000512	0.00267	CcSEcCtD
Gefitinib—Mediastinal disorder—Memantine—Alzheimer's disease	0.000508	0.00265	CcSEcCtD
Gefitinib—Arrhythmia—Memantine—Alzheimer's disease	0.000504	0.00263	CcSEcCtD
Gefitinib—Angiopathy—Rivastigmine—Alzheimer's disease	0.000501	0.00261	CcSEcCtD
Gefitinib—Anaemia—Donepezil—Alzheimer's disease	0.0005	0.00261	CcSEcCtD
Gefitinib—Alopecia—Memantine—Alzheimer's disease	0.000498	0.0026	CcSEcCtD
Gefitinib—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000497	0.0026	CcSEcCtD
Gefitinib—Decreased appetite—Galantamine—Alzheimer's disease	0.000495	0.00258	CcSEcCtD
Gefitinib—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000493	0.00257	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000492	0.00257	CcSEcCtD
Gefitinib—Malnutrition—Memantine—Alzheimer's disease	0.000491	0.00256	CcSEcCtD
Gefitinib—Fatigue—Galantamine—Alzheimer's disease	0.000491	0.00256	CcSEcCtD
Gefitinib—Malaise—Donepezil—Alzheimer's disease	0.000488	0.00254	CcSEcCtD
Gefitinib—Alopecia—Rivastigmine—Alzheimer's disease	0.000488	0.00254	CcSEcCtD
Gefitinib—Constipation—Galantamine—Alzheimer's disease	0.000487	0.00254	CcSEcCtD
Gefitinib—Malnutrition—Rivastigmine—Alzheimer's disease	0.00048	0.00251	CcSEcCtD
Gefitinib—Vandetanib—VEGFA—Alzheimer's disease	0.000479	0.0684	CrCbGaD
Gefitinib—Cough—Donepezil—Alzheimer's disease	0.000472	0.00246	CcSEcCtD
Gefitinib—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000466	0.00243	CcSEcCtD
Gefitinib—Anaemia—Memantine—Alzheimer's disease	0.000454	0.00237	CcSEcCtD
Gefitinib—Dry mouth—Donepezil—Alzheimer's disease	0.00045	0.00235	CcSEcCtD
Gefitinib—Abdominal pain—Galantamine—Alzheimer's disease	0.00045	0.00235	CcSEcCtD
Gefitinib—Body temperature increased—Galantamine—Alzheimer's disease	0.00045	0.00235	CcSEcCtD
Gefitinib—Anaemia—Rivastigmine—Alzheimer's disease	0.000444	0.00232	CcSEcCtD
Gefitinib—CYP2D6—forebrain—Alzheimer's disease	0.000444	0.0065	CbGeAlD
Gefitinib—Malaise—Memantine—Alzheimer's disease	0.000443	0.00231	CcSEcCtD
Gefitinib—Minaprine—SLC6A4—Alzheimer's disease	0.000443	0.0632	CrCbGaD
Gefitinib—Infection—Donepezil—Alzheimer's disease	0.000438	0.00229	CcSEcCtD
Gefitinib—Shock—Donepezil—Alzheimer's disease	0.000434	0.00227	CcSEcCtD
Gefitinib—Malaise—Rivastigmine—Alzheimer's disease	0.000433	0.00226	CcSEcCtD
Gefitinib—Nervous system disorder—Donepezil—Alzheimer's disease	0.000433	0.00226	CcSEcCtD
Gefitinib—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000432	0.00226	CcSEcCtD
Gefitinib—Cough—Memantine—Alzheimer's disease	0.000428	0.00224	CcSEcCtD
Gefitinib—Anorexia—Donepezil—Alzheimer's disease	0.000421	0.0022	CcSEcCtD
Gefitinib—Hypersensitivity—Galantamine—Alzheimer's disease	0.00042	0.00219	CcSEcCtD
Gefitinib—Cough—Rivastigmine—Alzheimer's disease	0.000419	0.00219	CcSEcCtD
Gefitinib—Hypotension—Donepezil—Alzheimer's disease	0.000412	0.00215	CcSEcCtD
Gefitinib—Dry mouth—Memantine—Alzheimer's disease	0.000409	0.00213	CcSEcCtD
Gefitinib—Asthenia—Galantamine—Alzheimer's disease	0.000409	0.00213	CcSEcCtD
Gefitinib—CYP2D6—telencephalon—Alzheimer's disease	0.000408	0.00597	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000406	0.00212	CcSEcCtD
Gefitinib—Dry mouth—Rivastigmine—Alzheimer's disease	0.0004	0.00209	CcSEcCtD
Gefitinib—Infection—Memantine—Alzheimer's disease	0.000398	0.00208	CcSEcCtD
Gefitinib—Shock—Memantine—Alzheimer's disease	0.000394	0.00206	CcSEcCtD
Gefitinib—Dyspnoea—Donepezil—Alzheimer's disease	0.000393	0.00205	CcSEcCtD
Gefitinib—ALB—brain—Alzheimer's disease	0.000393	0.00576	CbGeAlD
Gefitinib—Nervous system disorder—Memantine—Alzheimer's disease	0.000393	0.00205	CcSEcCtD
Gefitinib—Thrombocytopenia—Memantine—Alzheimer's disease	0.000392	0.00205	CcSEcCtD
Gefitinib—Diarrhoea—Galantamine—Alzheimer's disease	0.00039	0.00203	CcSEcCtD
Gefitinib—Infection—Rivastigmine—Alzheimer's disease	0.000389	0.00203	CcSEcCtD
Gefitinib—Skin disorder—Memantine—Alzheimer's disease	0.000389	0.00203	CcSEcCtD
Gefitinib—Shock—Rivastigmine—Alzheimer's disease	0.000386	0.00201	CcSEcCtD
Gefitinib—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000384	0.00201	CcSEcCtD
Gefitinib—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000384	0.002	CcSEcCtD
Gefitinib—Decreased appetite—Donepezil—Alzheimer's disease	0.000384	0.002	CcSEcCtD
Gefitinib—Anorexia—Memantine—Alzheimer's disease	0.000382	0.00199	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000381	0.00199	CcSEcCtD
Gefitinib—Skin disorder—Rivastigmine—Alzheimer's disease	0.000381	0.00199	CcSEcCtD
Gefitinib—Fatigue—Donepezil—Alzheimer's disease	0.00038	0.00199	CcSEcCtD
Gefitinib—Constipation—Donepezil—Alzheimer's disease	0.000377	0.00197	CcSEcCtD
Gefitinib—Pain—Donepezil—Alzheimer's disease	0.000377	0.00197	CcSEcCtD
Gefitinib—Hypotension—Memantine—Alzheimer's disease	0.000374	0.00195	CcSEcCtD
Gefitinib—Anorexia—Rivastigmine—Alzheimer's disease	0.000374	0.00195	CcSEcCtD
Gefitinib—Hypotension—Rivastigmine—Alzheimer's disease	0.000366	0.00191	CcSEcCtD
Gefitinib—Vomiting—Galantamine—Alzheimer's disease	0.000362	0.00189	CcSEcCtD
Gefitinib—ABCB1—embryo—Alzheimer's disease	0.000361	0.00528	CbGeAlD
Gefitinib—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000361	0.00188	CcSEcCtD
Gefitinib—Rash—Galantamine—Alzheimer's disease	0.000359	0.00187	CcSEcCtD
Gefitinib—Dermatitis—Galantamine—Alzheimer's disease	0.000359	0.00187	CcSEcCtD
Gefitinib—Dyspnoea—Memantine—Alzheimer's disease	0.000357	0.00186	CcSEcCtD
Gefitinib—Urticaria—Donepezil—Alzheimer's disease	0.000351	0.00183	CcSEcCtD
Gefitinib—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000349	0.00182	CcSEcCtD
Gefitinib—Abdominal pain—Donepezil—Alzheimer's disease	0.000349	0.00182	CcSEcCtD
Gefitinib—Body temperature increased—Donepezil—Alzheimer's disease	0.000349	0.00182	CcSEcCtD
Gefitinib—Decreased appetite—Memantine—Alzheimer's disease	0.000348	0.00182	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000346	0.00181	CcSEcCtD
Gefitinib—Fatigue—Memantine—Alzheimer's disease	0.000345	0.0018	CcSEcCtD
Gefitinib—Constipation—Memantine—Alzheimer's disease	0.000343	0.00179	CcSEcCtD
Gefitinib—Pain—Memantine—Alzheimer's disease	0.000343	0.00179	CcSEcCtD
Gefitinib—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000341	0.00178	CcSEcCtD
Gefitinib—Minaprine—HTR2A—Alzheimer's disease	0.00034	0.0486	CrCbGaD
Gefitinib—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000338	0.00177	CcSEcCtD
Gefitinib—Nausea—Galantamine—Alzheimer's disease	0.000338	0.00177	CcSEcCtD
Gefitinib—Fatigue—Rivastigmine—Alzheimer's disease	0.000338	0.00176	CcSEcCtD
Gefitinib—Constipation—Rivastigmine—Alzheimer's disease	0.000335	0.00175	CcSEcCtD
Gefitinib—Pain—Rivastigmine—Alzheimer's disease	0.000335	0.00175	CcSEcCtD
Gefitinib—CYP1A1—nervous system—Alzheimer's disease	0.000334	0.00488	CbGeAlD
Gefitinib—ABCG2—cerebellum—Alzheimer's disease	0.000331	0.00484	CbGeAlD
Gefitinib—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000328	0.00171	CcSEcCtD
Gefitinib—Hypersensitivity—Donepezil—Alzheimer's disease	0.000325	0.0017	CcSEcCtD
Gefitinib—CYP1A1—central nervous system—Alzheimer's disease	0.000321	0.0047	CbGeAlD
Gefitinib—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000321	0.00167	CcSEcCtD
Gefitinib—ABCB1—forebrain—Alzheimer's disease	0.000319	0.00467	CbGeAlD
Gefitinib—Urticaria—Memantine—Alzheimer's disease	0.000318	0.00166	CcSEcCtD
Gefitinib—Abdominal pain—Memantine—Alzheimer's disease	0.000317	0.00165	CcSEcCtD
Gefitinib—Body temperature increased—Memantine—Alzheimer's disease	0.000317	0.00165	CcSEcCtD
Gefitinib—Asthenia—Donepezil—Alzheimer's disease	0.000317	0.00165	CcSEcCtD
Gefitinib—Pruritus—Donepezil—Alzheimer's disease	0.000312	0.00163	CcSEcCtD
Gefitinib—Urticaria—Rivastigmine—Alzheimer's disease	0.000311	0.00163	CcSEcCtD
Gefitinib—Minaprine—CYP2D6—Alzheimer's disease	0.000311	0.0445	CrCbGaD
Gefitinib—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00031	0.00162	CcSEcCtD
Gefitinib—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00031	0.00162	CcSEcCtD
Gefitinib—Diarrhoea—Donepezil—Alzheimer's disease	0.000302	0.00158	CcSEcCtD
Gefitinib—Hypersensitivity—Memantine—Alzheimer's disease	0.000295	0.00154	CcSEcCtD
Gefitinib—ABCB1—telencephalon—Alzheimer's disease	0.000293	0.0043	CbGeAlD
Gefitinib—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000289	0.00151	CcSEcCtD
Gefitinib—Asthenia—Memantine—Alzheimer's disease	0.000287	0.0015	CcSEcCtD
Gefitinib—Pruritus—Memantine—Alzheimer's disease	0.000283	0.00148	CcSEcCtD
Gefitinib—Asthenia—Rivastigmine—Alzheimer's disease	0.000281	0.00147	CcSEcCtD
Gefitinib—Vomiting—Donepezil—Alzheimer's disease	0.000281	0.00146	CcSEcCtD
Gefitinib—Rash—Donepezil—Alzheimer's disease	0.000278	0.00145	CcSEcCtD
Gefitinib—Dermatitis—Donepezil—Alzheimer's disease	0.000278	0.00145	CcSEcCtD
Gefitinib—Pruritus—Rivastigmine—Alzheimer's disease	0.000277	0.00145	CcSEcCtD
Gefitinib—Diarrhoea—Memantine—Alzheimer's disease	0.000274	0.00143	CcSEcCtD
Gefitinib—Cisapride—HTR2A—Alzheimer's disease	0.000269	0.0384	CrCbGaD
Gefitinib—ABCG2—brain—Alzheimer's disease	0.000269	0.00393	CbGeAlD
Gefitinib—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000268	0.0014	CcSEcCtD
Gefitinib—Nausea—Donepezil—Alzheimer's disease	0.000262	0.00137	CcSEcCtD
Gefitinib—Erlotinib—CYP2D6—Alzheimer's disease	0.000261	0.0373	CrCbGaD
Gefitinib—CYP1A1—brain—Alzheimer's disease	0.000255	0.00373	CbGeAlD
Gefitinib—Vomiting—Memantine—Alzheimer's disease	0.000255	0.00133	CcSEcCtD
Gefitinib—Rash—Memantine—Alzheimer's disease	0.000253	0.00132	CcSEcCtD
Gefitinib—Dermatitis—Memantine—Alzheimer's disease	0.000252	0.00132	CcSEcCtD
Gefitinib—Vomiting—Rivastigmine—Alzheimer's disease	0.000249	0.0013	CcSEcCtD
Gefitinib—Iloperidone—HTR2A—Alzheimer's disease	0.000248	0.0355	CrCbGaD
Gefitinib—Rash—Rivastigmine—Alzheimer's disease	0.000247	0.00129	CcSEcCtD
Gefitinib—Dermatitis—Rivastigmine—Alzheimer's disease	0.000247	0.00129	CcSEcCtD
Gefitinib—Cisapride—CYP2D6—Alzheimer's disease	0.000246	0.0351	CrCbGaD
Gefitinib—CYP3A4—nervous system—Alzheimer's disease	0.000245	0.00358	CbGeAlD
Gefitinib—CYP2D6—nervous system—Alzheimer's disease	0.000241	0.00353	CbGeAlD
Gefitinib—Nausea—Memantine—Alzheimer's disease	0.000238	0.00124	CcSEcCtD
Gefitinib—CYP3A4—central nervous system—Alzheimer's disease	0.000236	0.00345	CbGeAlD
Gefitinib—Nausea—Rivastigmine—Alzheimer's disease	0.000233	0.00122	CcSEcCtD
Gefitinib—CYP2D6—central nervous system—Alzheimer's disease	0.000232	0.0034	CbGeAlD
Gefitinib—Iloperidone—CYP2D6—Alzheimer's disease	0.000227	0.0324	CrCbGaD
Gefitinib—CYP2D6—cerebellum—Alzheimer's disease	0.000227	0.00332	CbGeAlD
Gefitinib—CYP2D6—brain—Alzheimer's disease	0.000184	0.0027	CbGeAlD
Gefitinib—ABCB1—nervous system—Alzheimer's disease	0.000173	0.00254	CbGeAlD
Gefitinib—ABCB1—central nervous system—Alzheimer's disease	0.000167	0.00244	CbGeAlD
Gefitinib—ABCB1—cerebellum—Alzheimer's disease	0.000163	0.00239	CbGeAlD
Gefitinib—ABCB1—brain—Alzheimer's disease	0.000132	0.00194	CbGeAlD
Gefitinib—ALB—Metabolism—PTGS1—Alzheimer's disease	5.76e-06	3.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CREB1—Alzheimer's disease	5.74e-06	3.11e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—INS—Alzheimer's disease	5.71e-06	3.09e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	5.69e-06	3.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.66e-06	3.06e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP2D6—Alzheimer's disease	5.65e-06	3.06e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—AKT1—Alzheimer's disease	5.61e-06	3.04e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MTHFR—Alzheimer's disease	5.61e-06	3.04e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LPL—Alzheimer's disease	5.58e-06	3.02e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	5.54e-06	3e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CASP3—Alzheimer's disease	5.54e-06	3e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MEF2C—Alzheimer's disease	5.53e-06	2.99e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ACHE—Alzheimer's disease	5.52e-06	2.99e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—Alzheimer's disease	5.46e-06	2.96e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	5.46e-06	2.95e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.44e-06	2.94e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PRKCG—Alzheimer's disease	5.42e-06	2.94e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—AKT1—Alzheimer's disease	5.42e-06	2.93e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ACHE—Alzheimer's disease	5.39e-06	2.92e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	5.37e-06	2.91e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—BCHE—Alzheimer's disease	5.36e-06	2.9e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CASP3—Alzheimer's disease	5.34e-06	2.89e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INPP5D—Alzheimer's disease	5.32e-06	2.88e-05	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	5.31e-06	2.87e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—Alzheimer's disease	5.29e-06	2.86e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NGF—Alzheimer's disease	5.28e-06	2.86e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—Alzheimer's disease	5.25e-06	2.84e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CALM1—Alzheimer's disease	5.24e-06	2.84e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NOS3—Alzheimer's disease	5.24e-06	2.84e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	5.23e-06	2.83e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—APOE—Alzheimer's disease	5.22e-06	2.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—BCL2—Alzheimer's disease	5.22e-06	2.82e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CAV1—Alzheimer's disease	5.17e-06	2.8e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ENO1—Alzheimer's disease	5.17e-06	2.8e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	5.17e-06	2.8e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.16e-06	2.79e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR5—Alzheimer's disease	5.14e-06	2.78e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MAPK8—Alzheimer's disease	5.09e-06	2.76e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ACHE—Alzheimer's disease	5.08e-06	2.75e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	5.07e-06	2.74e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PLCB1—Alzheimer's disease	5.05e-06	2.74e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS1—Alzheimer's disease	5.05e-06	2.73e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ENO1—Alzheimer's disease	5.05e-06	2.73e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ACHE—Alzheimer's disease	5.03e-06	2.72e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—Alzheimer's disease	5.03e-06	2.72e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.02e-06	2.72e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS3—Alzheimer's disease	5e-06	2.71e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	4.97e-06	2.69e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.96e-06	2.68e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	4.95e-06	2.68e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MAPK8—Alzheimer's disease	4.91e-06	2.66e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	4.9e-06	2.65e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCA1—Alzheimer's disease	4.9e-06	2.65e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AKT1—Alzheimer's disease	4.88e-06	2.64e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	4.88e-06	2.64e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—Alzheimer's disease	4.85e-06	2.63e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—AKT1—Alzheimer's disease	4.84e-06	2.62e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—BCHE—Alzheimer's disease	4.81e-06	2.6e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.76e-06	2.57e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.76e-06	2.57e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	4.72e-06	2.55e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ENO1—Alzheimer's disease	4.72e-06	2.55e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—VEGFA—Alzheimer's disease	4.7e-06	2.55e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CALM1—Alzheimer's disease	4.69e-06	2.54e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.69e-06	2.54e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—APOE—Alzheimer's disease	4.68e-06	2.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—LEP—Alzheimer's disease	4.68e-06	2.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—Alzheimer's disease	4.64e-06	2.51e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CAV1—Alzheimer's disease	4.63e-06	2.51e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	4.63e-06	2.51e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	4.62e-06	2.5e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—Alzheimer's disease	4.61e-06	2.5e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	4.61e-06	2.5e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—Alzheimer's disease	4.58e-06	2.48e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARG—Alzheimer's disease	4.55e-06	2.46e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	4.54e-06	2.46e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—VEGFA—Alzheimer's disease	4.53e-06	2.45e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—Alzheimer's disease	4.5e-06	2.43e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—Alzheimer's disease	4.48e-06	2.42e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—AKT1—Alzheimer's disease	4.47e-06	2.42e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ESR1—Alzheimer's disease	4.46e-06	2.42e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—LPL—Alzheimer's disease	4.46e-06	2.42e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—INS—Alzheimer's disease	4.46e-06	2.41e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.45e-06	2.41e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CASP3—Alzheimer's disease	4.45e-06	2.41e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4.43e-06	2.4e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.42e-06	2.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—F2—Alzheimer's disease	4.41e-06	2.39e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	4.4e-06	2.38e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—BCHE—Alzheimer's disease	4.38e-06	2.37e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—Alzheimer's disease	4.32e-06	2.34e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOTCH1—Alzheimer's disease	4.32e-06	2.34e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.29e-06	2.32e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—VEGFA—Alzheimer's disease	4.29e-06	2.32e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.28e-06	2.32e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.28e-06	2.32e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—AKT1—Alzheimer's disease	4.28e-06	2.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MAPK8—Alzheimer's disease	4.23e-06	2.29e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARGC1A—Alzheimer's disease	4.22e-06	2.29e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—LPL—Alzheimer's disease	4.22e-06	2.28e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—HMOX1—Alzheimer's disease	4.2e-06	2.27e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.17e-06	2.26e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—Alzheimer's disease	4.16e-06	2.25e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	4.14e-06	2.24e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—AKT1—Alzheimer's disease	4.13e-06	2.24e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—Alzheimer's disease	4.12e-06	2.23e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—AKT1—Alzheimer's disease	4.11e-06	2.22e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.1e-06	2.22e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MAPK8—Alzheimer's disease	4.09e-06	2.21e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.06e-06	2.2e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GSK3B—Alzheimer's disease	4.05e-06	2.19e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.04e-06	2.19e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—Alzheimer's disease	4.04e-06	2.19e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	4.02e-06	2.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CREB1—Alzheimer's disease	4.02e-06	2.17e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	4.01e-06	2.17e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—INS—Alzheimer's disease	4e-06	2.16e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.95e-06	2.14e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—Alzheimer's disease	3.94e-06	2.13e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL2—Alzheimer's disease	3.93e-06	2.13e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NOS3—Alzheimer's disease	3.91e-06	2.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IGF1—Alzheimer's disease	3.86e-06	2.09e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—LPL—Alzheimer's disease	3.84e-06	2.08e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.81e-06	2.06e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AKT1—Alzheimer's disease	3.8e-06	2.06e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	3.8e-06	2.05e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	3.79e-06	2.05e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—VEGFA—Alzheimer's disease	3.77e-06	2.04e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	3.77e-06	2.04e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CALM1—Alzheimer's disease	3.75e-06	2.03e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—APOE—Alzheimer's disease	3.74e-06	2.02e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—AKT1—Alzheimer's disease	3.73e-06	2.02e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CAV1—Alzheimer's disease	3.71e-06	2.01e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.7e-06	2e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.68e-06	1.99e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—Alzheimer's disease	3.58e-06	1.94e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—Alzheimer's disease	3.55e-06	1.92e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CALM1—Alzheimer's disease	3.55e-06	1.92e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—APOE—Alzheimer's disease	3.53e-06	1.91e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NOS3—Alzheimer's disease	3.5e-06	1.9e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CAV1—Alzheimer's disease	3.5e-06	1.9e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.49e-06	1.89e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.47e-06	1.88e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—Alzheimer's disease	3.46e-06	1.88e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTHFR—Alzheimer's disease	3.46e-06	1.87e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.46e-06	1.87e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.45e-06	1.87e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.44e-06	1.86e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—Alzheimer's disease	3.43e-06	1.85e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—LPL—Alzheimer's disease	3.37e-06	1.82e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.32e-06	1.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—Alzheimer's disease	3.31e-06	1.79e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.28e-06	1.78e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.26e-06	1.76e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—Alzheimer's disease	3.25e-06	1.76e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—Alzheimer's disease	3.24e-06	1.75e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CALM1—Alzheimer's disease	3.23e-06	1.75e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—APOE—Alzheimer's disease	3.22e-06	1.74e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—INS—Alzheimer's disease	3.2e-06	1.73e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CAV1—Alzheimer's disease	3.19e-06	1.73e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.17e-06	1.72e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.15e-06	1.7e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—Alzheimer's disease	3.14e-06	1.7e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.11e-06	1.68e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.11e-06	1.68e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	3.11e-06	1.68e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—Alzheimer's disease	3.08e-06	1.67e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.05e-06	1.65e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.03e-06	1.64e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—INS—Alzheimer's disease	3.02e-06	1.63e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AKT1—Alzheimer's disease	3e-06	1.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CASP3—Alzheimer's disease	2.97e-06	1.61e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—Alzheimer's disease	2.96e-06	1.6e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.9e-06	1.57e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AKT1—Alzheimer's disease	2.89e-06	1.57e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.89e-06	1.57e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.89e-06	1.56e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.87e-06	1.55e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.86e-06	1.55e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—Alzheimer's disease	2.85e-06	1.54e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.83e-06	1.53e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.83e-06	1.53e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—APOE—Alzheimer's disease	2.82e-06	1.53e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—Alzheimer's disease	2.81e-06	1.52e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.8e-06	1.52e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.8e-06	1.51e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—INS—Alzheimer's disease	2.75e-06	1.49e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—AKT1—Alzheimer's disease	2.74e-06	1.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MAPK8—Alzheimer's disease	2.73e-06	1.48e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.73e-06	1.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AKT1—Alzheimer's disease	2.73e-06	1.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—Alzheimer's disease	2.7e-06	1.46e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.67e-06	1.44e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.66e-06	1.44e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.65e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.65e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.64e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.64e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.64e-06	1.43e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.61e-06	1.41e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—Alzheimer's disease	2.61e-06	1.41e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.56e-06	1.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—VEGFA—Alzheimer's disease	2.52e-06	1.37e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.52e-06	1.36e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—Alzheimer's disease	2.49e-06	1.35e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—AKT1—Alzheimer's disease	2.49e-06	1.35e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INS—Alzheimer's disease	2.47e-06	1.34e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.46e-06	1.33e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	2.42e-06	1.31e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NOS3—Alzheimer's disease	2.41e-06	1.31e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INS—Alzheimer's disease	2.41e-06	1.31e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AKT1—Alzheimer's disease	2.41e-06	1.3e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.32e-06	1.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—Alzheimer's disease	2.32e-06	1.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—AKT1—Alzheimer's disease	2.3e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.3e-06	1.24e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.28e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INS—Alzheimer's disease	2.27e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.27e-06	1.23e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INS—Alzheimer's disease	2.25e-06	1.22e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—Alzheimer's disease	2.21e-06	1.19e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.17e-06	1.17e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.11e-06	1.14e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.07e-06	1.12e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.99e-06	1.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.98e-06	1.07e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.98e-06	1.07e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.93e-06	1.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—Alzheimer's disease	1.91e-06	1.03e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.87e-06	1.01e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	9.87e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.81e-06	9.78e-06	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AKT1—Alzheimer's disease	1.8e-06	9.73e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—Alzheimer's disease	1.75e-06	9.45e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.75e-06	9.45e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.74e-06	9.41e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.72e-06	9.33e-06	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-06	8.72e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.51e-06	8.2e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INS—Alzheimer's disease	1.49e-06	8.04e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.3e-06	7.05e-06	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.29e-06	6.97e-06	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.22e-06	6.59e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.19e-06	6.45e-06	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AKT1—Alzheimer's disease	1.11e-06	6.01e-06	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AKT1—Alzheimer's disease	9.96e-07	5.39e-06	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AKT1—Alzheimer's disease	9.72e-07	5.26e-06	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AKT1—Alzheimer's disease	9.16e-07	4.96e-06	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AKT1—Alzheimer's disease	9.08e-07	4.92e-06	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.99e-07	3.24e-06	CbGpPWpGaD
